Metropolitan Life Insurance Company (MetLife)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,867
| Closed | -$367K | – | 2497 |
|
2022
Q4 | $367K | Buy |
1,867
+96
| +5% | +$18.9K | 0.02% | 532 |
|
2022
Q3 | $398K | Buy |
1,771
+185
| +12% | +$41.6K | 0.02% | 515 |
|
2022
Q2 | $201K | Buy |
1,586
+182
| +13% | +$23K | 0.01% | 693 |
|
2022
Q1 | $178K | Sell |
1,404
-4,339
| -76% | -$550K | 0.01% | 875 |
|
2021
Q4 | $752K | Sell |
5,743
-384
| -6% | -$50.3K | 0.01% | 1149 |
|
2021
Q3 | $750K | Buy |
+6,127
| New | +$750K | 0.01% | 1170 |
|
2021
Q2 | – | Sell |
-4,499
| Closed | -$541K | – | 2912 |
|
2021
Q1 | $541K | Sell |
4,499
-276
| -6% | -$33.2K | 0.01% | 1363 |
|
2020
Q4 | $485K | Hold |
4,775
| – | – | 0.01% | 1368 |
|
2020
Q3 | $369K | Hold |
4,775
| – | – | 0.01% | 1413 |
|
2020
Q2 | $532K | Buy |
4,775
+1,497
| +46% | +$167K | 0.01% | 1157 |
|
2020
Q1 | $236K | Buy |
3,278
+1,652
| +102% | +$119K | ﹤0.01% | 1501 |
|
2019
Q4 | $123K | Buy |
+1,626
| New | +$123K | ﹤0.01% | 2209 |
|